These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 10769136)

  • 1. A novel approach to serine protease inhibition: kinetic characterization of inhibitors whose potencies and selectivities are dramatically enhanced by Zinc(II).
    Janc JW; Clark JM; Warne RL; Elrod KC; Katz BA; Moore WR
    Biochemistry; 2000 Apr; 39(16):4792-800. PubMed ID: 10769136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxyanion-mediated inhibition of serine proteases.
    Presnell SR; Patil GS; Mura C; Jude KM; Conley JM; Bertrand JA; Kam CM; Powers JC; Williams LD
    Biochemistry; 1998 Dec; 37(48):17068-81. PubMed ID: 9836602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitors of tryptase for the treatment of mast cell-mediated diseases.
    Rice KD; Tanaka RD; Katz BA; Numerof RP; Moore WR
    Curr Pharm Des; 1998 Oct; 4(5):381-96. PubMed ID: 10197050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polycationic peptides as inhibitors of mast cell serine proteases.
    Lundequist A; Juliano MA; Juliano L; Pejler G
    Biochem Pharmacol; 2003 Apr; 65(7):1171-80. PubMed ID: 12663052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soybean Bowman-Birk protease inhibitor is a highly effective inhibitor of human mast cell chymase.
    Ware JH; Wan XS; Rubin H; Schechter NM; Kennedy AR
    Arch Biochem Biophys; 1997 Aug; 344(1):133-8. PubMed ID: 9244390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bivalent inhibition of human beta-tryptase.
    Schaschke N; Matschiner G; Zettl F; Marquardt U; Bergner A; Bode W; Sommerhoff CP; Moroder L
    Chem Biol; 2001 Apr; 8(4):313-27. PubMed ID: 11325588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetic and thermodynamic analysis of leech-derived tryptase inhibitor interaction with bovine tryptase and bovine trypsin.
    Erba F; Fiorucci L; Sommerhoff CP; Coletta M; Ascoli F
    Biol Chem; 2000 Nov; 381(11):1117-22. PubMed ID: 11154069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and evaluation of diphenyl phosphonate esters as inhibitors of the trypsin-like granzymes A and K and mast cell tryptase.
    Jackson DS; Fraser SA; Ni LM; Kam CM; Winkler U; Johnson DA; Froelich CJ; Hudig D; Powers JC
    J Med Chem; 1998 Jun; 41(13):2289-301. PubMed ID: 9632362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histone-tryptase interaction: H2A N-terminal tail removal and inhibitory activity.
    Fiorucci L; Erba F; Ascoli F
    Arch Biochem Biophys; 1997 Nov; 347(2):229-34. PubMed ID: 9367529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure of the complex of leech-derived tryptase inhibitor (LDTI) with trypsin and modeling of the LDTI-tryptase system.
    Di Marco S; Priestle JP
    Structure; 1997 Nov; 5(11):1465-74. PubMed ID: 9384562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spontaneous inactivation of human tryptase involves conformational changes consistent with conversion of the active site to a zymogen-like structure.
    Selwood T; McCaslin DR; Schechter NM
    Biochemistry; 1998 Sep; 37(38):13174-83. PubMed ID: 9748324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of human mast cell tryptase by benzamidine derivatives.
    Stürzebecher J; Prasa D; Sommerhoff CP
    Biol Chem Hoppe Seyler; 1992 Oct; 373(10):1025-30. PubMed ID: 1418674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and evaluation of 4-substituted benzylamine derivatives as beta-tryptase inhibitors.
    Miyazaki Y; Kato Y; Manabe T; Shimada H; Mizuno M; Egusa T; Ohkouchi M; Shiromizu I; Matsusue T; Yamamoto I
    Bioorg Med Chem Lett; 2006 Jun; 16(11):2986-90. PubMed ID: 16540315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nafamostat mesilate is an extremely potent inhibitor of human tryptase.
    Mori S; Itoh Y; Shinohata R; Sendo T; Oishi R; Nishibori M
    J Pharmacol Sci; 2003 Aug; 92(4):420-3. PubMed ID: 12939527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel serine protease inhibition motif involving a multi-centered short hydrogen bonding network at the active site.
    Katz BA; Elrod K; Luong C; Rice MJ; Mackman RL; Sprengeler PA; Spencer J; Hataye J; Janc J; Link J; Litvak J; Rai R; Rice K; Sideris S; Verner E; Young W
    J Mol Biol; 2001 Apr; 307(5):1451-86. PubMed ID: 11292354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitors of serine proteases as potential therapeutic agents: the road from thrombin to tryptase to cathepsin G.
    Maryanoff BE
    J Med Chem; 2004 Feb; 47(4):769-87. PubMed ID: 14761180
    [No Abstract]   [Full Text] [Related]  

  • 17. Selective inhibition of human mast cell tryptase by gabexate mesylate, an antiproteinase drug.
    Erba F; Fiorucci L; Pascarella S; Menegatti E; Ascenzi P; Ascoli F
    Biochem Pharmacol; 2001 Feb; 61(3):271-6. PubMed ID: 11172730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of potent and selective 2-azepanone inhibitors of human tryptase.
    Zhao G; Bolton SA; Kwon C; Hartl KS; Seiler SM; Slusarchyk WA; Sutton JC; Bisacchi GS
    Bioorg Med Chem Lett; 2004 Jan; 14(2):309-12. PubMed ID: 14698147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pericellular substrates of human mast cell tryptase: 72,000 dalton gelatinase and fibronectin.
    Lohi J; Harvima I; Keski-Oja J
    J Cell Biochem; 1992 Dec; 50(4):337-49. PubMed ID: 1469068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potent bivalent inhibition of human tryptase-beta by a synthetic inhibitor.
    Selwood T; Elrod KC; Schechter NM
    Biol Chem; 2003 Dec; 384(12):1605-11. PubMed ID: 14719803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.